Capricor Therapeutics
CAPR
#7633
Rank
S$0.56 B
Marketcap
S$9.79
Share price
0.80%
Change (1 day)
30.38%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2026 (TTM): S-$3.16

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$3.16. In 2025 the company made an earnings per share (EPS) of S-$2.92 a decrease over its 2024 EPS that were of S-$1.55.

EPS history for Capricor Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$3.168.27%
2025S-$2.9288.33%
2024S-$1.55
2022S-$1.5235.63%
2021S-$1.12-7.45%
2020S-$1.21-55.45%
2019S-$2.72-59.81%
2018S-$6.77-1850%
2017S$0.39-102.94%
2016S-$13.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-372.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$8.99-384.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S-$7.79 146.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.61 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S-$9.74 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$37.78 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA